Clearside Biomedical CLSD reported its Q4 earnings results on Thursday, March 10, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Clearside Biomedical beat estimated earnings by 93.75%, reporting an EPS of $0.31 versus an estimate of $0.16.
Revenue was up $25.68 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 1.21% drop in the share price the next day.
Here's a look at Clearside Biomedical's past performance:
Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
---|---|---|---|---|
EPS Estimate | -0.08 | -0.12 | -0.10 | -0.11 |
EPS Actual | -0.08 | -0.11 | -0.13 | -0.14 |
Revenue Estimate | 2.58M | 690.00K | 2.12M | 1.29M |
Revenue Actual | 3.07M | 780.00K | 34.00K | 11.00K |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.